The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or without aura, Axsome Therapeutics announced. Meloxicam is a COX-2 preferential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results